|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.745 SEK | 0.00% |
|
-8.59% | -32.27% |
| 10/04 | Vaxxa AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 23/02 | Vaxxa AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
Augeo Group AB reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was SEK 15.05 million compared to SEK 1.38 million a year ago. Revenue was SEK 15.29 million compared to SEK 1.57 million a year ago.
Net loss was SEK 33.5 million compared to SEK 6.99 million a year ago.
VAXXA AB 